POTENTIAL ADVERSE EFFECTS AND DRUG INTERACTIONS OF ALISKIREN
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty, Covilhã, Portugal)
- Co-author(s): Ema Paulino
Aliskiren is an antihypertensive drug and it acts by inhibition of the renin enzyme. The introduction of this drug in the European Union is relatively recent, reporting to the year of 2007.
Literature review through research and analysis of articles published at PubMed, found by intersecting the terms “aliskiren interactions” and “aliskiren adverse.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.